Consistency evaluation of sodium fluochloroxine for injection of drugs under Fosun Pharma

Medical Network May 14 hearing before flucloxacillin sodium for injection to evaluate the agreement Fosun subsidiary of Guilin Pharmaceutical filed a supplemental application to obtain CDE contractor acceptance, acceptance number CYHB2050235, CYHB2050236, CYHB2050237Meters within the network data show that in 2019 Chinese public medical institutions terminal flucloxacillin injection sales of 435 million yuanGuilin Pharmaceutical declaration of conformity for the product evaluation company firstflucloxacillin sodium (FlucloxacillinSodium) for the fourth generation semi-synthetic penicillin isoxazole, first by the British company Beecham (now part of the British company GSK) in the 1970s, research and development, trade name Floxapen listed forms are capsules, powderIn 2007, GSK company has authorized the British company Actavis 0.25g, 0.5g, 1.0g in European production sales Floxapen, market sizemeters within the network data show that China's urban public2019 years, the county-level public hospitals, urban community centers and township hospitals (referred to as the Chinese public medical institutions) terminal flucloxacillin injection sales 435 million yuan, Guilin Pharmaceutical occupy 47.24% of market shareChinese public sector terminal CFC sales amoxicillin injection (unit: million)domestic market seven pharmaceutical companies have flucloxacillin sodium for injection production approval , respectively Guilin pharmaceutical, stone medicine Connaught, the day of Stmedicine, pharmacy Sunrise, moist pharmaceuticals, beautiful Xilin Hainan, Shanxi Zhendong pharmaceutical Tai Shingmeter display network evaluation database consistency, flucloxacillin sodium injection No listing application by a new classification, for the first reporting consistency Guilin Pharmaceutical Evaluation of EnterprisesSource: m network database